Oric Pharmaceuticals (ORIC) News Today $13.90 +0.74 (+5.62%) Closing price 10/15/2025 04:00 PM EasternExtended Trading$13.58 -0.32 (-2.27%) As of 10/15/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ORIC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Recommendation of "Moderate Buy" by AnalystsOctober 14 at 2:14 AM | marketbeat.comOric Pharmaceuticals' (ORIC) Sell (D-) Rating Reiterated at Weiss RatingsOctober 10, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) CFO Sells $159,720.00 in StockOctober 9, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) CEO Jacob Chacko Sells 37,461 SharesOctober 9, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) CFO Dominic Piscitelli Sells 11,000 SharesOctober 9, 2025 | insidertrades.comOric Pharmaceuticals (NASDAQ:ORIC) Sets New 12-Month High - Still a Buy?October 7, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) Trading Up 9.8% - Here's What HappenedOctober 6, 2025 | marketbeat.comWe're Not Very Worried About ORIC Pharmaceuticals' (NASDAQ:ORIC) Cash Burn RateOctober 4, 2025 | finance.yahoo.comOric Pharmaceuticals (NASDAQ:ORIC) CEO Jacob Chacko Sells 34,538 SharesOctober 3, 2025 | insidertrades.comOric Pharmaceuticals (NASDAQ:ORIC) CEO Sells $414,801.38 in StockOctober 2, 2025 | marketbeat.comInsider Selling: Oric Pharmaceuticals (NASDAQ:ORIC) CEO Sells 53,001 Shares of StockOctober 2, 2025 | marketbeat.comOric Pharmaceuticals Hits 80-Plus Relative Strength Rating BenchmarkSeptember 25, 2025 | msn.comPalumbo Wealth Management LLC Takes Position in Oric Pharmaceuticals, Inc. $ORICSeptember 25, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) CEO Sells $1,350,000.00 in StockSeptember 24, 2025 | marketbeat.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Recommendation of "Moderate Buy" by BrokeragesSeptember 19, 2025 | marketbeat.comOric Pharmaceuticals management to meet virtually with Cantor FitzgeraldSeptember 17, 2025 | msn.comFred Alger Management LLC Sells 40,554 Shares of Oric Pharmaceuticals, Inc. $ORICSeptember 12, 2025 | marketbeat.comTrexquant Investment LP Invests $425,000 in Oric Pharmaceuticals, Inc. $ORICSeptember 10, 2025 | marketbeat.com203,006 Shares in Oric Pharmaceuticals, Inc. $ORIC Bought by Parkman Healthcare Partners LLCSeptember 8, 2025 | marketbeat.comORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)September 5, 2025 | globenewswire.comOric Pharmaceuticals, Inc. $ORIC Shares Bought by Rafferty Asset Management LLCSeptember 5, 2025 | marketbeat.comOric Pharmaceuticals assumed with a Buy at GuggenheimSeptember 4, 2025 | msn.comAlkeon Capital Management LLC Buys 100,000 Shares of Oric Pharmaceuticals, Inc. $ORICSeptember 4, 2025 | marketbeat.comMPM Bioimpact LLC Takes $7.81 Million Position in Oric Pharmaceuticals, Inc. $ORICSeptember 4, 2025 | marketbeat.comFrazier Life Sciences Management L.P. Has $7.87 Million Stock Position in Oric Pharmaceuticals, Inc. $ORICSeptember 4, 2025 | marketbeat.comORIC Pharmaceuticals, Inc. (ORIC) Pharmaceuticals, Inc. Presents at Citi's Biopharma Back to School Conference - SlideshowSeptember 3, 2025 | seekingalpha.comORIC Pharmaceuticals, Inc. (ORIC) Pharmaceuticals, Inc. Presents At Citi's Biopharma Back To School Conference TranscriptSeptember 3, 2025 | seekingalpha.comStocks To Watch: Oric Pharmaceuticals Sees RS Rating Jump To 82September 3, 2025 | msn.comNuveen LLC Makes New Investment in Oric Pharmaceuticals, Inc. $ORICSeptember 3, 2025 | marketbeat.comDAFNA Capital Management LLC Purchases New Holdings in Oric Pharmaceuticals, Inc. $ORICSeptember 1, 2025 | marketbeat.comORIC® Pharmaceuticals to Participate in Upcoming Investor ConferencesAugust 27, 2025 | globenewswire.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Average Rating of "Moderate Buy" by BrokeragesAugust 27, 2025 | marketbeat.comThis ORIC Pharmaceuticals Insider Increased Their Holding In The Last YearAugust 24, 2025 | finance.yahoo.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) Short Interest Down 45.0% in JulyAugust 20, 2025 | marketbeat.comORIC Pharmaceuticals: ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical OfficerAugust 19, 2025 | finanznachrichten.deORIC Pharmaceuticals Reports Q2 2025 Financial ResultsAugust 19, 2025 | msn.comOric Pharmaceuticals appoints Kevin Brodbeck CTOAugust 19, 2025 | msn.comEquities Analysts Offer Predictions for ORIC Q3 EarningsAugust 19, 2025 | marketbeat.comORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical OfficerAugust 18, 2025 | globenewswire.comWedbush Predicts Weaker Earnings for Oric PharmaceuticalsAugust 17, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) Upgraded to Hold at Zacks ResearchAugust 17, 2025 | marketbeat.comJPMorgan Chase & Co. Has Lowered Expectations for Oric Pharmaceuticals (NASDAQ:ORIC) Stock PriceAugust 16, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) Given New $19.00 Price Target at HC WainwrightAugust 16, 2025 | marketbeat.comOric Pharmaceuticals' (ORIC) Buy Rating Reiterated at GuggenheimAugust 15, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) Posts Earnings Results, Misses Expectations By $0.01 EPSAugust 14, 2025 | marketbeat.comOric Pharmaceuticals Focuses on Lead Clinical ProgramsAugust 12, 2025 | msn.comOric Pharmaceuticals reports Q2 EPS (47c), consensus (44c)August 12, 2025 | msn.comOric Pharmaceuticals Logs Wider 2Q Loss, Plans to Cut 20% of WorkforceAugust 12, 2025 | marketwatch.comORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational UpdatesAugust 12, 2025 | globenewswire.comVivo Capital LLC Purchases 802,632 Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC)August 9, 2025 | marketbeat.com Get Oric Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ORIC Media Mentions By Week ORIC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORIC News Sentiment▼0.560.72▲Average Medical News Sentiment ORIC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORIC Articles This Week▼75▲ORIC Articles Average Week Get the Latest News and Ratings for ORIC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Oric Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies PTC Therapeutics News Today Krystal Biotech News Today Arrowhead Pharmaceuticals News Today Arcellx News Today Akero Therapeutics News Today Crinetics Pharmaceuticals News Today Jyong Biotech News Today NewAmsterdam Pharma News Today Kymera Therapeutics News Today Scholar Rock News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORIC) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNvidia CEO shares biggest regret?Earlier this year I predicted that the only reason Elon was in Washington was to push an AI-first agenda. Sinc...Altimetry | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oric Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oric Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
